Skip to content
Trial Eligibility
Menu

Safe and Explainable AI

NCT06694181

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

While current AI technology is suitable for automating some repetitive clinical tasks, technical challenges remain in solving critical and gainful problems in the domains of patient and disease management. The proposed research seeks to address issues in medical AI, such as integrating medical knowledge effectively, making AI recommendations explainable to clinicians, and establishing safety guarantees.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Artifical Inteligence
  • Cardiology
  • Breast Cancer
  • Sepsis

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Abramson Cancer Center at Penn Medicine
Last updated on ClinicalTrials.gov
February 25, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • Hospital of the University of Pennsylvania · Philadelphia, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.